Research graph

References

References from Beyond calprotectin: where leucine-rich α2-glycoprotein may fit in small bowel Crohn disease monitoring. Local targets link to admitted publications; unresolved targets remain external evidence.

The clinical significance of serum C reactive protein levels in Crohn’s disease. Results of a prospective longitudinal study

10.1097/00004836-198808000-00011 · 1988 · External reference

Usefulness of C-reactive protein as a disease activity marker in Crohn’s disease according to the location of disease

10.5009/gnl13424 · 2015 · External reference

Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn’s disease activity

10.1002/jgh3.12068 · 2018 · External reference

Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn’s disease?: a systematic review

10.5217/ir.2018.00114 · 2019 · External reference

Diagnostic accuracy of fecal calprotectin for the detection of small bowel Crohn’s disease through capsule endoscopy: an updated meta-analysis and systematic review

10.5009/gnl20249 · 2021 · External reference

AGA clinical practice guideline on the role of biomarkers for the management of Crohn’s disease

10.1053/j.gastro.2023.09.029 · 2023 · External reference

STRIDE-II: An update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD

10.1053/j.gastro.2020.12.031 · 2021 · External reference

Comparative efficiency of leucine-rich alpha-2 glycoprotein and fecal calprotectin to assess endoscopic activity in Crohn’s disease: a prospective observational study

10.1093/ibd/izag105 · 2026 · Admitted local publication

Leucine-rich alpha-2 glycoprotein is a serum biomarker of mucosal healing in ulcerative colitis

10.1093/ecco-jcc/jjw132 · 2017 · External reference

Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis

10.1002/ibd.22936 · 2012 · External reference

Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease

10.1038/s41598-021-90441-x · 2021 · External reference

Serum leucine-rich α2 glycoprotein: a novel biomarker for small bowel mucosal activity in Crohn’s disease

10.1016/j.cgh.2021.06.036 · 2022 · External reference

Unresolved reference

External reference

Faecal calprotectin

2018 · External reference

Compliance with the faecal calprotectin test in patients with inflammatory bowel disease

10.1177/2050640616686517 · 2017 · External reference